Global Health Ltd
Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]
- Market Cap ₹ 32,185 Cr.
- Current Price ₹ 1,198
- High / Low ₹ 1,511 / 936
- Stock P/E 82.0
- Book Value ₹ 114
- Dividend Yield 0.00 %
- ROCE 17.6 %
- ROE 13.5 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 41.7% CAGR over last 5 years
Cons
- Stock is trading at 10.6 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 13.2% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Part of BSE 500 BSE SmallCap Select Index BSE 400 MidSmallCap Index Nifty LargeMidcap 250 BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|
1,277 | 1,343 | 1,441 | 1,472 | 1,227 | 1,765 | 1,974 | 2,280 | 2,479 | |
1,158 | 1,218 | 1,297 | 1,253 | 1,054 | 1,384 | 1,551 | 1,777 | 1,935 | |
Operating Profit | 119 | 125 | 144 | 219 | 173 | 381 | 423 | 503 | 544 |
OPM % | 9% | 9% | 10% | 15% | 14% | 22% | 21% | 22% | 22% |
67 | 49 | 64 | 43 | 28 | 35 | 47 | 103 | 105 | |
Interest | 19 | 24 | 21 | 33 | 29 | 33 | 32 | 30 | 23 |
Depreciation | 77 | 86 | 91 | 99 | 88 | 87 | 86 | 87 | 95 |
Profit before tax | 89 | 64 | 97 | 131 | 84 | 296 | 352 | 489 | 531 |
Tax % | 39% | 42% | 35% | 22% | 32% | 26% | 25% | 26% | |
54 | 37 | 63 | 103 | 57 | 219 | 263 | 361 | 392 | |
EPS in Rs | 11.21 | 7.70 | 12.81 | 20.82 | 11.55 | 8.64 | 9.82 | 13.44 | 14.62 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 23% |
TTM: | 13% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 42% |
3 Years: | 85% |
TTM: | 12% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -9% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 13% |
Last Year: | 14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 48 | 81 | 49 | 49 | 50 | 51 | 54 | 54 | 54 |
Reserves | 1,070 | 1,141 | 1,230 | 1,341 | 1,434 | 1,689 | 2,435 | 2,795 | 2,995 |
215 | 168 | 168 | 51 | 228 | 308 | 288 | 260 | 223 | |
303 | 318 | 310 | 517 | 291 | 314 | 402 | 414 | 475 | |
Total Liabilities | 1,637 | 1,709 | 1,758 | 1,958 | 2,002 | 2,361 | 3,179 | 3,523 | 3,746 |
966 | 1,162 | 869 | 929 | 851 | 827 | 810 | 841 | 1,037 | |
CWIP | 8 | 7 | 5 | 3 | 4 | 6 | 75 | 184 | 259 |
Investments | 21 | 0 | 356 | 500 | 626 | 734 | 765 | 790 | 791 |
642 | 540 | 528 | 525 | 521 | 794 | 1,529 | 1,708 | 1,659 | |
Total Assets | 1,637 | 1,709 | 1,758 | 1,958 | 2,002 | 2,361 | 3,179 | 3,523 | 3,746 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
124 | 152 | 193 | 201 | 235 | 431 | 341 | ||
-112 | -104 | -45 | -250 | -313 | -257 | -699 | ||
-6 | -49 | -56 | -37 | 98 | 404 | -66 | ||
Net Cash Flow | 6 | -1 | 92 | -86 | 20 | 577 | -424 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 31 | 41 | 42 | 37 | 39 | 36 | 32 | 31 |
Inventory Days | 36 | 26 | 26 | 37 | 39 | 33 | 34 | 30 |
Days Payable | 132 | 124 | 142 | 135 | 134 | 84 | 113 | 93 |
Cash Conversion Cycle | -66 | -56 | -74 | -61 | -56 | -16 | -48 | -32 |
Working Capital Days | -23 | -4 | -7 | -11 | -10 | 8 | -13 | -1 |
ROCE % | 6% | 8% | 11% | 7% | 17% | 16% | 18% |
Documents
Announcements
-
Closure of Trading Window
27 Mar - Closure of trading window from April 01, 2025.
-
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
26 Mar - Merger of Medanta Holdings with Global Health Limited.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22 Mar - Schedule of analysts/investors meeting on March 27-28, 2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22 Mar - Schedule of analysts/institutional investors meeting.
-
Announcement under Regulation 30 (LODR)-Credit Rating
18 Mar - CRISIL Ratings increased loan rating to Rs. 1500 Crore.
Annual reports
Concalls
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Dec 2022TranscriptNotesPPT
Hospital Count[1] Global Health operates five hospitals under the "Medanta" brand in Gurugram, Indore, Ranchi, Lucknow, and Patna, with one more hospital under construction in Noida. The company provides services in over 30 medical specialties, employing 1,750+ doctors across a total area of 4.7 million square feet.
The operational hospitals have 3,008 installed beds. In addition, Global Health runs 6 multi-specialty clinics in locations such as DLF Cybercity Gurugram, Delhi Airport, South Delhi, Darbhanga, Patna, and Subhash Chowk Gurugram.[2]